StockData
Apollomics Inc. logo

Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30
$17.84+0.16 (+0.90%)

Close on Nov 16, 2026Market cap $39.18MP/E –Yield –

Apollomics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Apollomics's price to sales ratio was 3.2× on Nov 11, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.2×–

More Apollomics figures

See a number that looks wrong?